Checkmate or Stalemate: Valeant’s fall from investing grace
Published on Nov 13, 2015
In this session, I look at Valeant’s rise from obscure Canadian drug company to a value investing darling, and its precipitous fall in the last three weeks.
Slides: http://www.stern.nyu.edu/~adamodar/pd…
Valuation: http://www.stern.nyu.edu/~adamodar/pc…
Blog Post: http://aswathdamodaran.blogspot.com/2…
